Non-pneumonitis immune-mediated adverse events (imAEs) with durvalumab in patients with unresectable stage III NSCLC (PACIFIC).

---

Naidoo J., Vansteenkiste J. F., Faivre-Finn C., Ozguroglu M., Murakami S., Hui R., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.38, no.15, 2020 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 38 Issue: 15
• Publication Date: 2020
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
• Istanbul University Affiliated: Yes